Psychotropic Medication and Psychotropic Polypharmacy Among Children and Adolescents in the US Child Welfare System

被引：5
|
作者：
Radel, Laura F. [1 ]
Ali, Mir M. [1 ,3 ]
West, Kristina [1 ]
Lieff, Sarah A. [2 ]
机构：
[1] US Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, Washington, DC USA
[2] Math, Washington, DC USA
[3] US Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, 200 Independence Ave SW, Washington, DC 20202 USA
来源：
JAMA PEDIATRICS | 2023年 / 177卷 / 10期
关键词：
D O I：
10.1001/jamapediatrics.2023.3068
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
This cross-sectional study evaluates rates of psychotropic medication and polypharmacy use among youths in the US child welfare system compared with other youths with Medicaid coverage in 2019.
引用
收藏
页码：1107 / 1110
页数：4
相关论文
共 50 条
  • [41] Recent international trends in psychotropic medication prescriptions for children and adolescents
    Hans-Christoph Steinhausen
    European Child & Adolescent Psychiatry, 2015, 24 : 635 - 640
  • [42] Recent trends in psychotropic medication use in children and adolescents in Ireland
    Parkin, Rebecca
    Bennett, Kathleen
    Nicholas, Fiona Mc
    Hayden, John C.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2025, 34 (03) : 997 - 1009
  • [43] Psychotropic Medication Use in Children and Adolescents With Type 1 Diabetes
    Liu, Shengxin
    Lagerberg, Tyra
    Ludvigsson, Jonas F.
    Taylor, Mark J.
    Chang, Zheng
    D'Onofrio, Brian M.
    Larsson, Henrik
    Lichtenstein, Paul
    Gudbjornsdottir, Soffia
    Kuja-Halkola, Ralf
    Butwicka, Agnieszka
    JAMA NETWORK OPEN, 2023, 6 (10) : E2336621
  • [44] Psychotropic medication use among publicly insured US youth
    Valluri, Satish C.
    Kouzis, Anthony
    Zito, Julie M.
    Gardner, James F.
    Korelitz, James
    Bethel, James
    Lasky, Tamar
    Gerber, Russell A.
    Safer, Daniel J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S14 - S14
  • [45] Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease
    Orsel, Kim
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Koponen, Marjaana
    Tanskanen, Antti
    Tiihonen, Jari
    Gardarsdottir, Helga
    Hartikainen, Sirpa
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (11) : 1260 - 1269
  • [46] Psychotropic drug use and psychotropic polypharmacy among persons with Alzheimer's disease
    Orsel, Kim
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Koponen, Marjaana
    Tanskanen, Antti
    Tiihonen, Jari
    Gardarsdottir, Helga
    Hartikainen, Sirpa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 294 - 294
  • [47] Psychiatric Diagnoses and Prescribing Patterns of Psychotropic Polypharmacy among Children and Adolescents in the Jazan Region, Saudi Arabia
    Meraya, Abdulkarim M.
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020, 30 (01) : 24 - 30
  • [48] Minding the complexities of psychotropic medication management for children and youth in the foster care system Paper 2: Levels of trauma responsiveness among child welfare staff
    Bertram, Julie E.
    McKanry, Jennifer
    ARCHIVES OF PSYCHIATRIC NURSING, 2022, 41 : 68 - 73
  • [49] Psychotropic Polypharmacy Among Youths Enrolled in Medicaid
    Chiang, Yueh-Yi
    Amill-Rosario, Alejandro
    Tran, Phuong
    Dosreis, Susan
    JAMA NETWORK OPEN, 2024, 7 (02) : E2356404
  • [50] IMPACT OF PANDEMIC ON PSYCHIATRIC DISORDERS, SERVICE UTILIZATION, AND PSYCHOTROPIC MEDICATION USE AMONG CHILDREN AND ADOLESCENTS
    Baweja, Raman
    Waschbusch, Daniel A.
    Baweja, Ritika
    Waxmonsky, James G.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 63 (10): : S319 - S319
12345